Fig. 9From: Exploration of the aptitude to alleviate oxidative impairment and curb colorectal cancer manifestation by Nostoc calcicola in HT-29 adenocarcinoma cellsEffect of Nostoc calcicola on cell cycle progression of HT-29 cells using flow cytometry. a Control cells, b–d Nostoc calcicola-treated cells at different concentrations representing cell cycle arrest in S phaseBack to article page